Kiyomi Mashima

Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

British journal of haematology

ImmunoHorizons

Research square

Leukemia & lymphoma

Jichi Medical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Jichi Medical University Apr 01 2015

Japan

Medical Doctor :: Hematology

Publications

Jennifer R Brown, Kiyomi Mashima, Stacey Fernandes, Aishath Naeem, Samantha Shupe, Rayan Fardoun, Matthew S Davids
Mutations Detected in Real World Clinical Sequencing during BTK Inhibitor Treatment in CLL. Research square (2024)
Jennifer R Brown, Kiyomi Mashima, Stacey Fernandes, Aishath Naeem, Samantha Shupe, Rayan Fardoun, Matthew S Davids
Mutations Detected in Real World Clinical Sequencing during BTK Inhibitor Treatment in CLL. Research square (2024)
Hirofumi Nakano, Kazuya Sato, Junko Izawa, Norihito Takayama, Hiroko Hayakawa, Takashi Ikeda, Shin-Ichiro Kawaguchi, Kiyomi Mashima, Kento Umino, Kaoru Morita, Ryoji Ito, Nobuhiko Ohno, Kaoru Tominaga, Hitoshi Endo, Yoshinobu Kanda
Fatty Acids Play a Critical Role in Mitochondrial Oxidative Phosphorylation in Effector T Cells in Graft-versus-Host Disease. ImmunoHorizons 8 (3) (2024)
Hirofumi Nakano, Kazuya Sato, Junko Izawa, Norihito Takayama, Hiroko Hayakawa, Takashi Ikeda, Shin-Ichiro Kawaguchi, Kiyomi Mashima, Kento Umino, Kaoru Morita, Ryoji Ito, Nobuhiko Ohno, Kaoru Tominaga, Hitoshi Endo, Yoshinobu Kanda
Fatty Acids Play a Critical Role in Mitochondrial Oxidative Phosphorylation in Effector T Cells in Graft-versus-Host Disease. ImmunoHorizons 8 (3) (2024)
Hirofumi Nakano, Kazuya Sato, Junko Izawa, Norihito Takayama, Hiroko Hayakawa, Takashi Ikeda, Shin-Ichiro Kawaguchi, Kiyomi Mashima, Kento Umino, Kaoru Morita, Ryoji Ito, Nobuhiko Ohno, Kaoru Tominaga, Hitoshi Endo, Yoshinobu Kanda
Fatty Acids Play a Critical Role in Mitochondrial Oxidative Phosphorylation in Effector T Cells in Graft-versus-Host Disease. ImmunoHorizons 8 (3) (2024)
Daisuke Minakata, Shin-Ichiro Fujiwara, Daizo Yokoyama, Atsuto Noguchi, Shuka Aoe, Takashi Oyama, Shunsuke Koyama, Rui Murahashi, Hirotomo Nakashima, Kazuki Hyodo, Takashi Ikeda, Shin-Ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kiyomi Mashima, Kento Umino, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Yoshinobu Kanda
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies. British journal of haematology 200 (6) (2023)
Daisuke Minakata, Shin-Ichiro Fujiwara, Daizo Yokoyama, Atsuto Noguchi, Shuka Aoe, Takashi Oyama, Shunsuke Koyama, Rui Murahashi, Hirotomo Nakashima, Kazuki Hyodo, Takashi Ikeda, Shin-Ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kiyomi Mashima, Kento Umino, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Yoshinobu Kanda
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies. British journal of haematology 200 (6) (2023)
Daisuke Minakata, Shin-Ichiro Fujiwara, Daizo Yokoyama, Atsuto Noguchi, Shuka Aoe, Takashi Oyama, Shunsuke Koyama, Rui Murahashi, Hirotomo Nakashima, Kazuki Hyodo, Takashi Ikeda, Shin-Ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kiyomi Mashima, Kento Umino, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Yoshinobu Kanda
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies. British journal of haematology 200 (6) (2023)
Daisuke Minakata, Shin-Ichiro Fujiwara, Daizo Yokoyama, Atsuto Noguchi, Shuka Aoe, Takashi Oyama, Shunsuke Koyama, Rui Murahashi, Hirotomo Nakashima, Kazuki Hyodo, Takashi Ikeda, Shin-Ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kiyomi Mashima, Kento Umino, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Yoshinobu Kanda
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies. British journal of haematology (2023)
Kiyomi Mashima, Kazuya Sato, Takashi Ikeda, Junko Izawa, Norihito Takayama, Hiroko Hayakawa, Shin-Ichiro Kawaguchi, Hirofumi Nakano, Takashi Nagayama, Kento Umino, Kaoru Morita, Kaoru Tominaga, Hitoshi Endo, Yoshinobu Kanda
Dimethyl fumarate ameliorates graft-versus-host disease by inhibiting T-cell metabolism and immune responses through a reactive oxygen species-dependent mechanism. British journal of haematology 197 (6) (2022)
Benjamin L Lampson, Aditi Gupta, Svitlana Tyekucheva, Kiyomi Mashima, Anna Petráčková, Zixu Wang, Natalia Wojciechowska, Conner J Shaughnessy, Peter O Baker, Stacey M Fernandes, Samantha Shupe, John-Hanson Machado, Rayan Fardoun, Annette S Kim, Jennifer R Brown
Rare Germline ATM Variants Influence the Development of Chronic Lymphocytic Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Kiyomi Mashima, Iekuni Oh, Ken Fujiwara, Junko Izawa, Norihito Takayama, Hirofumi Nakano, Yasufumi Kawasaki, Daisuke Minakata, Ryoko Yamasaki, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Shin-Ichiro Fujiwara, Nobuhiko Ohno, Yoshinobu Kanda
Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models. PloS one 16 (1) (2021)
Kaoru Morita, Shin-Ichiro Fujiwara, Takashi Ikeda, Shin-Ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Takashi Nagayama, Kiyomi Mashima, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Yoshinobu Kanda
Identification of endoscopic factors that predict poor responses to steroids in patients with gastrointestinal acute graft-versus-host disease. Bone marrow transplantation 56 (4) (2020)
Kento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, Shin-Ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Shin-Ichi Ochi, Takashi Nagayama, Kiyomi Mashima, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Kaoru Morita, Yasufumi Kawasaki, Chihiro Yamamoto, Masahiro Ashizawa, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda
Impact of the soluble interleukin-2 receptor level in the relapsed or refractory phase on the clinical outcome of patients with diffuse large B-cell lymphoma. Leukemia & lymphoma 60 (8) (2019)
Kento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, Yumiko Toda, Shoko Ito, Kiyomi Mashima, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Yasufumi Kawasaki, Miyuki Sugimoto, Chihiro Yamamoto, Masahiro Ashizawa, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda
Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement. Hematology (Amsterdam, Netherlands) 23 (8) (2018)

Kiyomi Mashima.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kiyomi Mashima